Yu Y - Search Results

1

Synthesis and activity evaluation of selenazole-coupled CPI-1 irreversible bifunctional inhibitors for botulinum toxin A light chain.

Liu J, Xu S, Huang C, Shen J, Yu S, Yu Y, Sun Q, Dai Q. Liu J, et al. Among authors: yu s, yu y. Bioorg Med Chem Lett. 2022 Oct 1;73:128913. doi: 10.1016/j.bmcl.2022.128913. Epub 2022 Jul 29. Bioorg Med Chem Lett. 2022. PMID: 35914651

2

Development and preclinical evaluation of a new F(ab')₂ antitoxin against botulinum neurotoxin serotype A.

Yu YZ, Zhang SM, Wang WB, Du Y, Zhu HQ, Wang RL, Zhou XW, Lin JB, Wang S, Yu WY, Huang PT, Sun ZW. Yu YZ, et al. Among authors: yu wy. Biochimie. 2010 Oct;92(10):1315-20. doi: 10.1016/j.biochi.2010.06.010. Epub 2010 Jun 18. Biochimie. 2010. PMID: 20600570

3

Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A.

Yu YZ, Ma Y, Chen YX, Gong ZW, Wang S, Yu WY, Sun ZW. Yu YZ, et al. Among authors: yu wy. Hum Vaccin. 2011 Oct;7(10):1090-5. doi: 10.4161/hv.7.10.16763. Epub 2011 Oct 1. Hum Vaccin. 2011. PMID: 21941093

4

Enhanced effects of DNA vaccine against botulinum neurotoxin serotype A by targeting antigen to dendritic cells.

Chen BY, Zhou G, Li QL, Lu JS, Shi DY, Pang XB, Zhou XW, Yu YZ, Huang PT. Chen BY, et al. Immunol Lett. 2017 Oct;190:118-124. doi: 10.1016/j.imlet.2017.08.004. Epub 2017 Aug 9. Immunol Lett. 2017. PMID: 28802641

5

Development and evaluation of a tetravalent botulinum vaccine.

Shi DY, Liu FJ, Li ZY, Mao YY, Lu JS, Wang R, Pang XB, Yu YZ, Yang ZX. Shi DY, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2048621. doi: 10.1080/21645515.2022.2048621. Epub 2022 Apr 18. Hum Vaccin Immunother. 2022. PMID: 35435814 Free PMC article.

6

Rapid and sensitive detection of botulinum toxin type A in complex sample matrices by AlphaLISA.

Zhang L, Lv Q, Zheng Y, Gao S, Huang W, Liu P, Kong D, Wang Y, Yu Y, Jiang Y, Jiang H. Zhang L, et al. Among authors: yu y. Front Public Health. 2022 Oct 20;10:987517. doi: 10.3389/fpubh.2022.987517. eCollection 2022. Front Public Health. 2022. PMID: 36339146 Free PMC article.

7

A Single Amino Acid Replacement Boosts the Analgesic Activity of α-Conotoxin AuIB through the Inhibition of the GABA_BR-Coupled N-Type Calcium Channel.

Wei Y, Zhang M, Yu S, Huang Q, Chen R, Xu S, Huang Y, Yu Y, Liao M, Dai Q. Wei Y, et al. Among authors: yu s, yu y. Mar Drugs. 2022 Nov 29;20(12):750. doi: 10.3390/md20120750. Mar Drugs. 2022. PMID: 36547897 Free PMC article.

8

Biological and Immunological Characterization of a Functional L-HN Derivative of Botulinum Neurotoxin Serotype F.

Li Z, Li B, Lu J, Liu X, Tan X, Wang R, Du P, Yu S, Xu Q, Pang X, Yu Y, Yang Z. Li Z, et al. Among authors: yu s, yu y. Toxins (Basel). 2023 Mar 6;15(3):200. doi: 10.3390/toxins15030200. Toxins (Basel). 2023. PMID: 36977091 Free PMC article.

9

Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.

Shi DY, Lu JS, Mao YY, Liu FJ, Wang R, Du P, Yu S, Yu YZ, Yang ZX. Shi DY, et al. Appl Microbiol Biotechnol. 2023 May;107(10):3205-3216. doi: 10.1007/s00253-023-12515-2. Epub 2023 Apr 14. Appl Microbiol Biotechnol. 2023. PMID: 37058230 Free PMC article.

10

Tetanus toxin and botulinum neurotoxin-derived fusion molecules are effective bivalent vaccines.

Li BL, Wang JR, Liu XY, Lu JS, Wang R, Du P, Yu S, Pang XB, Yu YZ, Yang ZX. Li BL, et al. Appl Microbiol Biotechnol. 2023 Dec;107(23):7197-7211. doi: 10.1007/s00253-023-12796-7. Epub 2023 Sep 23. Appl Microbiol Biotechnol. 2023. PMID: 37741939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37,982 results

Search Page